StocksNOVO-NORDISK A/S-SPONS ADRNVO

NVO

NOVO-NORDISK A/S-SPONS ADR

106.01 1.60 (1.53%)
Prețuri indicate cu întârziere de NASDAQ în USD Piața închisă
Tranzacționează
S
105.86
B
106.10

Novo-Nordisk A/S SPONS ADR

Novo Nordisk A/S to przedsiębiorstwo farmaceutyczne specjalizujące się w wytwarzaniu produktów insulinowych – lider w leczeniu cukrzycy. Założenie marki miało miejsce w 1923 roku, a jej siedziba znajduje się w duńskim Bagsvaerd. Produkty Novo Nordisk A/S są sprzedawane na całym świecie, a na NYSE do... Arată alte
Luna trecută
2,825
Urmăritori
0.13%
Investitori
100% Of them have BUY positions.
A decrease of -0.51% from last trading Day

Piețe corelate

Essity AB ser. B
ESSITYB.ST
10.20 (3.75%)
S
282.15
B
282.75
Bodycote PLC
BOY.L
-3.00 (-0.37%)
S
817.26
B
819.74
Heineken Holding NV
HEIO.NV
0.63 (0.81%)
S
77.63
B
77.82
Trigano SA
TRI.PA
4.50 (2.86%)
S
161.55
B
162.05
TransUnion
TRU
1.38 (1.20%)
S
116.20
B
116.47
Afișează mai mult

Investitori

Afișează mai mult
Primele
MumuSan7
$NOVO-B.CO (Novo Nordisk B A/S) $NVO (Novo-Nordisk A/S SPONS ADR) can someone please explain the difference between these 2 Shares? I think about an Investment in Novo Nordisk. Which one should be my choice?Traducere
Like ComenteazăDistribuie
2 răspunsuri
null
.
Jamie Leinhardt
I have mentioned before that my strategy has at least in part been inspired by Terry Smith (of Fundsmith) who runs a concentrated fund of quality companies. You can read about it in this post on my website: “𝘽𝙪𝙮 𝙜𝙤𝙤𝙙 𝙘𝙤𝙢𝙥𝙖𝙣𝙞𝙚𝙨. 𝘿𝙤𝙣'𝙩 𝙤𝙫𝙚𝙧𝙥𝙖𝙮. 𝘿𝙤 𝙣𝙤𝙩𝙝𝙞𝙣𝙜.” www.JamieMarc.com/insights1.php I've... Arată alte Traducere
Like ComenteazăDistribuie
null
.
Federico Gustincic
Editat
VALUATION MATTERS $NOVO-B.CO (Novo Nordisk B A/S) $NVO (Novo-Nordisk A/S SPONS ADR) reached a super high valuation. Novo Nordisk is an amazing company, which holds about 50% of the insulin market. It's super dominant and still growing very well. But the valuation it reached looks really scary to... Arată alte Traducere
Like ComenteazăDistribuie
2 răspunsuri
null
.
Arnaud Lazare
𝘼 𝙣𝙚𝙬 𝙨𝙩𝙤𝙘𝙠 𝙚𝙣𝙩𝙚𝙧𝙨 𝙤𝙪𝙧 𝙥𝙤𝙧𝙩𝙛𝙤𝙡𝙞𝙤! Dear Investors, Copiers and Followers, One in eleven people in the world suffers from diabetes and, if no action is taken to reverse the trend, this proportion is expected to rise to one in nine people by 2045. Obesity is not to be outdone,... Arată alte Traducere
Like ComenteazăDistribuie
null
.
Marco Giannini
Buonasera, come vi avevo predetto alcuni post fa, tramite alcune mie analisi, preannunciavo verso la metà di settembre dei giorni rossi Ma questo non ci spaventa, nel nostro portafoglio abbiamo molte posizioni che sono in calo, ed è questo il bello, pké tutte queste partiranno a razzo🚀appena ci sarà... Arată alte Traducere
Like ComenteazăDistribuie
null